{"category":{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T06:07:27.677Z","updated_at":"2026-09-03T06:07:27.677Z","example":false,"profile_url":"/industries/gene-therapy","is_stub":true,"member_count":14,"member_counts":{"company":14}},"members":[{"listing_type":"company","name":"FinalDose","slug":"finaldose","tagline":"Programmable DNA drug destroying all cancers, unlocking 80% of targets","description":"FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition.  Unlocking 80% of undruggable targets today. Starting with all cancers.\n\nFinalDose is a Y Combinator company (Spring 2026). YC-listed status: Active.","url":"https://www.finaldose.ai/","is_stealth":false,"normalized_domain":"finaldose.ai","normalized_url_key":"finaldose.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5910d81ebbfb17b7489c9613332140c02f40b7f4.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/finaldose","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Artificial Intelligence","Gene Therapy","Genetic Engineering"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:15:27.382Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Spring 2026","Artificial Intelligence","Gene Therapy","Therapeutics","Genetic Engineering"],"one_liner_for_search":"FinalDose — Programmable DNA drug destroying all cancers, unlocking 80% of targets (Y Combinator Spring 2026)","canonical_facts":["Y Combinator batch: Spring 2026","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:15:27.382Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"genetic-engineering","name":"Genetic Engineering","note":null,"profile_url":"/industries/genetic-engineering"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:15:27.382Z","updated_at":"2026-09-03T08:15:27.382Z"}},{"listing_type":"company","name":"Uncommon Therapeutics","slug":"uncommon-therapeutics","tagline":"A Disease Focused Biotech, Building Multiple Billion Dollar Drugs","description":"Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.\n\nUncommon Therapeutics is a Y Combinator company (Winter 2025). YC-listed status: Active.","url":"https://www.uncommontherapeutics.com/","is_stealth":false,"normalized_domain":"uncommontherapeutics.com","normalized_url_key":"uncommontherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/791a2a1e71f62bafa47311d3711d9cab4712eea4.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/uncommon-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","CRISPR","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:54:06.858Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2025","Gene Therapy","CRISPR","Biotechnology"],"one_liner_for_search":"Uncommon Therapeutics — A Disease Focused Biotech, Building Multiple Billion Dollar Drugs (Y Combinator Winter 2025)","canonical_facts":["Y Combinator batch: Winter 2025","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:54:06.858Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:54:06.858Z","updated_at":"2026-09-03T07:54:06.858Z"}},{"listing_type":"company","name":"Kopra Bio","slug":"kopra-bio","tagline":"Genetically engineered viruses that teach your immune system to kill…","description":"Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.\n\nKopra Bio is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.kopra.bio/","is_stealth":false,"normalized_domain":"kopra.bio","normalized_url_key":"kopra.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/acdb0c2a3124d9e5717a63d0231af9b6f7447919.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kopra-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:49:28.291Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Gene Therapy","Synthetic Biology","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"Kopra Bio — Genetically engineered viruses that teach your immune system to kill… (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: GlioTx","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:49:28.291Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:49:28.291Z","updated_at":"2026-09-03T07:49:28.291Z"}},{"listing_type":"company","name":"ParcelBio","slug":"parcelbio","tagline":"Elevated mRNA for transformative medicines.","description":"ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.\n\nParcelBio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://parcelbio.com/","is_stealth":false,"normalized_domain":"parcelbio.com","normalized_url_key":"parcelbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/74f762bd0f8856c1dbe4d716afa6585e44f03870.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/parcelbio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Synthetic Biology","Biotech","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:46:05.163Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Gene Therapy","Synthetic Biology","Biotech","Therapeutics","Drug discovery"],"one_liner_for_search":"ParcelBio — Elevated mRNA for transformative medicines. (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Parcel Therapuetics, Parcel Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:46:05.163Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:46:05.163Z","updated_at":"2026-09-03T07:46:05.163Z"}},{"listing_type":"company","name":"Modulari-T","slug":"modulari-t","tagline":"We teach your immune system to attack and cure cancer","description":"Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.\n\nModulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue.\n\nModulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.\n\nModulari-T is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/cdfde836f1d168c7ec0299ab6b4daf90d112f929.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/modulari-t","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"Montreal, QC, Canada; San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:22.865Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"one_liner_for_search":"Modulari-T — We teach your immune system to attack and cure cancer (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Modulari-T Biosciences","Regions (per YC): Canada, United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:22.865Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:22.865Z","updated_at":"2026-09-03T07:28:22.865Z"}},{"listing_type":"company","name":"WhiteLab Genomics","slug":"whitelab-genomics","tagline":"Unleashing the potential of DNA and RNA based therapies using AI","description":"We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.\n\nWhiteLab Genomics is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://whitelabgx.com/","is_stealth":false,"normalized_domain":"whitelabgx.com","normalized_url_key":"whitelabgx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ba69864f65b85fda9f05c3280bc3b39f42500013.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/whitelab-genomics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Artificial Intelligence","Gene Therapy","Cell Therapy","Genomics"],"stage":null,"founded_year":null,"location":"Paris, Île-de-France, France; Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:19.037Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Artificial Intelligence","Gene Therapy","Cell Therapy","Genomics"],"one_liner_for_search":"WhiteLab Genomics — Unleashing the potential of DNA and RNA based therapies using AI (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 40","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): France, United States of America, Europe, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:19.037Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:19.037Z","updated_at":"2026-09-03T07:11:19.037Z"}},{"listing_type":"company","name":"Andson Biotech","slug":"andson-biotech","tagline":"Empowering Mass Spec for Biotech and Beyond","description":"Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.\n\nAndson Biotech is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"http://www.andsonbiotech.com/","is_stealth":false,"normalized_domain":"andsonbiotech.com","normalized_url_key":"andsonbiotech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/8495f5832705b897265e143f4ea26b9403783542.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/andson-biotech","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Gene Therapy","Hard Tech","Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":"Atlanta, GA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:07:30.325Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Gene Therapy","Hard Tech","Biotech","Healthcare","Therapeutics"],"one_liner_for_search":"Andson Biotech — Empowering Mass Spec for Biotech and Beyond (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:07:30.325Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:07:30.325Z","updated_at":"2026-09-03T07:07:30.325Z"}},{"listing_type":"company","name":"Nuntius Therapeutics","slug":"nuntius-therapeutics","tagline":"Cell-specific genetic medicines","description":"Cell-specific genetic medicines\n\nNuntius Therapeutics is a Y Combinator company (Winter 2021). YC-listed status: Active.","url":"https://nuntiustx.com/","is_stealth":false,"normalized_domain":"nuntiustx.com","normalized_url_key":"nuntiustx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/490dca692522bd958768d197eafc08f9ea77c8fb.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nuntius-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Nanomedicine"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:47:05.586Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2021","Gene Therapy","Nanomedicine"],"one_liner_for_search":"Nuntius Therapeutics — Cell-specific genetic medicines (Y Combinator Winter 2021)","canonical_facts":["Y Combinator batch: Winter 2021","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:47:05.586Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:47:05.586Z","updated_at":"2026-09-03T06:47:05.586Z"}},{"listing_type":"company","name":"Nephrogen","slug":"nephrogen","tagline":"Curative genetic medicines for kidney diseases","description":"Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. \n\nNephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies including Merck KGaA, Novartis, and Bristol Myers Squibb.\n\nNephrogen is a Y Combinator company (Summer 2020). YC-listed status: Active.","url":"https://www.nephrogenbiotech.com/","is_stealth":false,"normalized_domain":"nephrogenbiotech.com","normalized_url_key":"nephrogenbiotech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ce4f8b04c9fefa06f0088d04f45b91af1e3fe8aa.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nephrogen","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","CRISPR","Biotech"],"stage":null,"founded_year":null,"location":"New York City, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:35:29.787Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2020","Gene Therapy","CRISPR","Biotech"],"one_liner_for_search":"Nephrogen — Curative genetic medicines for kidney diseases (Y Combinator Summer 2020)","canonical_facts":["Y Combinator batch: Summer 2020","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:35:29.787Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:35:29.787Z","updated_at":"2026-09-03T06:35:29.787Z"}},{"listing_type":"company","name":"Rejuvenation Technologies Inc.","slug":"rejuvenation-technologies-inc","tagline":"mRNA therapeutics to extend healthspan entering clinical trials","description":"Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.\n\nRejuvenation Technologies Inc. is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://rejuvenationtech.com/","is_stealth":false,"normalized_domain":"rejuvenationtech.com","normalized_url_key":"rejuvenationtech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/8570f907143e200c57848585eb12a16271d3643f.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/rejuvenation-technologies-inc","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:17:37.982Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Anti-Aging","Gene Therapy","Nanomedicine"],"one_liner_for_search":"Rejuvenation Technologies Inc. — mRNA therapeutics to extend healthspan entering clinical trials (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Rejuvenation Technologies Inc., Rejuvenation Technologies","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:17:37.982Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/industries/anti-aging"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:17:37.982Z","updated_at":"2026-09-03T06:17:37.982Z"}},{"listing_type":"company","name":"Perception Biosystems","slug":"perception-biosystems","tagline":"Democratizing gene therapy by reinventing its manufacturing and…","description":"Perception Biosystems is democratizing gene therapy through lab automation. Our mission is to accelerate the clinical translation of gene therapy by reinventing its manufacturing and development processes.\n\nWe're building a robotic lab in the SF Bay Area to translate the large facilities, labor, and regulatory requirements of current gene therapy factories into automated flexible manufacturing systems and code. This enables us to produce gene therapies for use in human clinical trials an order of magnitude faster and cheaper than the current solution – opening up thousands of rare disease targets otherwise thought too rare to pursue.\n\nPerception Biosystems is a Y Combinator company (Summer 2018). YC-listed status: Inactive.","url":"https://www.perception.bio/","is_stealth":false,"normalized_domain":"perception.bio","normalized_url_key":"perception.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6725a216e652408a9448418d0067920052e512a2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/perception-biosystems","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.perception.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.perception.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Biotech"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Palo Alto, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:17:30.646Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Gene Therapy","Biotech"],"one_liner_for_search":"Perception Biosystems — Democratizing gene therapy by reinventing its manufacturing and… (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Inactive","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Reformer Therapeutics, Perception Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:17:30.646Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:17:30.646Z","updated_at":"2026-09-03T06:17:30.646Z"}},{"listing_type":"company","name":"64x Bio","slug":"64x-bio","tagline":"Enabling next generation medicines. A comprehensive platform and…","description":"The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.\n\nOur VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.\n\n64x Bio is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://64xbio.com/","is_stealth":false,"normalized_domain":"64xbio.com","normalized_url_key":"64xbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/cfea1f5fda223a069c00cebbc1559d75a397a3f2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/64x-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://64xbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://64xbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Gene Therapy","Machine Learning"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:16:07.044Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Gene Therapy","Machine Learning"],"one_liner_for_search":"64x Bio — Enabling next generation medicines. A comprehensive platform and… (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 25","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: 64-X, 64-x","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:16:07.044Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:16:07.044Z","updated_at":"2026-09-03T06:16:07.044Z"}},{"listing_type":"company","name":"Sixfold Bioscience","slug":"sixfold-bioscience","tagline":"Delivering RNA therapies.","description":"Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.\n\nSixfold Bioscience is a Y Combinator company (Winter 2018). YC-listed status: Active.","url":"https://www.sixfold.bio/","is_stealth":false,"normalized_domain":"sixfold.bio","normalized_url_key":"sixfold.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b0f895aea5a3becf96dd016714d9e8aa78189e1b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sixfold-bioscience","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Gene Therapy","Nanomedicine","Drug Delivery"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:11:22.969Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2018","Gene Therapy","Nanomedicine","Drug Delivery"],"one_liner_for_search":"Sixfold Bioscience — Delivering RNA therapies. (Y Combinator Winter 2018)","canonical_facts":["Y Combinator batch: Winter 2018","YC company status: Active","Team size (per YC directory): 27","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Sixfold Bioscience","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:11:22.969Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:11:22.969Z","updated_at":"2026-09-03T06:11:22.969Z"}},{"listing_type":"company","name":"Indee Labs","slug":"indee-labs","tagline":"Enabling T cell immunotherapy discovery, development and manufacturing","description":"Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.\n\nIndee Labs is a Y Combinator company (Winter 2017). YC-listed status: Active.","url":"https://www.indeelabs.com/","is_stealth":false,"normalized_domain":"indeelabs.com","normalized_url_key":"indeelabs.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ac1b20e8e540ce71927b19ed6cbc32f9956f9290.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/indee-labs","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.indeelabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.indeelabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Gene Therapy","Microfluidics","Cell Therapy"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Berkeley, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:07:27.677Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2017","Gene Therapy","Microfluidics","Cell Therapy"],"one_liner_for_search":"Indee Labs — Enabling T cell immunotherapy discovery, development and manufacturing (Y Combinator Winter 2017)","canonical_facts":["Y Combinator batch: Winter 2017","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:07:27.677Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"microfluidics","name":"Microfluidics","note":null,"profile_url":"/industries/microfluidics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:07:27.677Z","updated_at":"2026-09-03T06:07:27.677Z"}}],"total":14,"limit":50,"offset":0}